(MedPage Today) — Elevated plasma tau phosphorylated at threonine 217 (p-tau217) foreshadowed cognitive decline and progression to dementia in people with Down syndrome, data from the longitudinal Alzheimer’s Biomarker Consortium-Down Syndrome…
(MedPage Today) — Elevated plasma tau phosphorylated at threonine 217 (p-tau217) foreshadowed cognitive decline and progression to dementia in people with Down syndrome, data from the longitudinal Alzheimer’s Biomarker Consortium-Down Syndrome…
